D-Dimer, a Biomarker for Diagnosis and Prognosis Assessment of COVID-19

Authors: Cheepsattayakorn A , Cheepsattayakorn R and Siriwanarangsun P

DOI: 10.23880/oajprs-16000149

Volume 6, Issue 1

Abstract

Coagulopathy [1] and increased levels of antiphospholipid antibodies [2] are more prevalent in critically ill-COVID-19 patients and may predispose patients to both arterial and venous thrombotic diseases, due to blood circulation stasis, endothelial dysfunction, platelet activation, and excessive inflammation.

Keywords: D-Dimer; Biomarker for Diagnosis; Prognosis; COVID-19

View PDF